About US
Contact us
-
Merz swoops into Obagi deal with $385M bid, topping ValeantThese days, dermatology is the belle of the ball. Drugmakers have been wooing small players in the skin-treatment field, and just last month, Valeant Pharmaceuticals ($VRX) announced that it had agre2013/4/3
-
Lilly bets on new insulin products with $180M plant additionEli Lilly ($LLY) has made a huge bet on insulin to help it maneuver past patent losses for drugs like antidepressant Cymbalta which falls off this year. It has four new products in development, inclu2013/4/3
-
J&J faces big spending, big rivals for new diabetes drug InvokanaJohnson & Johnson's new diabetes drug Invokana, previously known as canagliflozin, is the first FDA-approved treatment in a new class. That's something of a double-edged sword. It offers the prom2013/4/2
-
As Novartis loses Glivec bid, India's war on pharma patents threatens to spreadNovartis ($NVS) lost its last bid for an Indian patent on its cancer drug Glivec. As the nation's Supreme Court prepared to rule Big Pharma braced itself for impact. India has blazed a patent-slashin2013/4/2
-
Alexion gets FDA warning but doesn't expect Soliris disruptionAlexion is facing a tough situation for a one-hit wonder. It has been issued an FDA warning letter for its manufacturing plant where it makes its only approved drug--the rare-disease, and very pricey2013/4/1
-
Drugmakers need to think local in emerging markets, execs sayDrugmakers know by now that emerging markets aren't a quick fix. Though fast-developing countries such as China and India offer the promise of fast growth in drug sales, it's more difficult to tap th2013/4/1
-
Roche's Japanese arm gets green light for new arthritis drug trialChugai has been given the go-ahead to start clinical trials of its new arthritis treatment in Japan. The Japanese subsidiary of Roche has confirmed that regulators in the country have given the offic2013/3/29
-
Biopharmaceutical clinical trials boost Texas economyOver the last 13 years, biopharmaceutical companies in the US have conducted more than 8,200 clinical trials of new medicines in Texas.That is according to the Pharmaceutical Research and Manufacture2013/3/29
-
Novo, Sanofi duke it out in diabetes marketIf you've been following Novo Nordisk's ($NVO) new diabetes drugTresiba, you know that it will take aim at Sanofi's ($SNY) big gorilla of a basal insulin drug,Lantus. The stakes are huge for Sanofi,2013/3/28
-
ASCO aims Big Data at cancer treatmentTheAmerican Society of Clinical Oncologyis developing a database ofcancerpatients that could change the way doctors select treatments. With medical records on millions of people, the Big Data project2013/3/28